Predicting abuse potential of stimulants and other dopaminergic drugs: Overview and recommendations

Neuropharmacology

Volumn 87, Issue , 2014, Pages 66-80

  Huskinson, Sally L ^a   Naylor, Jennifer E ^a   Rowlett, James K ^a   Freeman, Kevin B ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Abuse potential; Animal model; Drug discrimination; Physical dependence; Self administration; Stimulant

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4' METHYLMETHCATHINONE; AMFEBUTAMONE; AMFEPRAMONE; AMINOREX; APOMORPHINE; ARIPIPRAZOLE; BROMOCRIPTINE; CATHINONE; COCAINE; DEXAMPHETAMINE; DICLOFENSINE; DOPAMINE RECEPTOR STIMULATING AGENT; LISDEXAMFETAMINE; MAZINDOL; METHAMPHETAMINE; METHCATHINONE; METHYLONE; METHYLPHENIDATE; MODAFINIL; NOMIFENSINE; PHENMETRAZINE; PIRIBEDIL; PRAMIPEXOLE; PROCAINE; PROPYLHEXEDRINE; PSYCHOSTIMULANT AGENT; ROPINIROLE; VANOXERINE; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; DECISION TREE; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG MEGADOSE; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG SELF ADMINISTRATION; HUMAN; LOW DRUG DOSE; NONHUMAN; PARKINSON DISEASE; PRACTICE GUIDELINE; PREDICTION; PRIMATE MODEL; RAT MODEL; REINFORCEMENT; REVIEW; WITHDRAWAL SYNDROME; ANIMAL; DISEASE MODEL; PATHOPHYSIOLOGY; PROCEDURES; SUBSTANCE-RELATED DISORDERS;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; DRUG EVALUATION, PRECLINICAL; HUMANS; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 84908512301     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.03.009     Document Type: Review

References (194)

1. S.M. Aarde, D. Angrish, D.J. Barlow, M.J. Wright, S.A. Vandewater, and K.M. Creehan Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats Addict. Biol. 18 2013 786 799
2. S.M. Aarde, P.K. Huang, K.M. Creehan, T.J. Dickerosn, and M.A. Taffe The novel recreational drug 3,4-methylenedioxyprovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats Neuropharmacol 71 2013 130 140
3. C. Achat-Mendes, D.M. Platt, and R.D. Spealman Antagonism of metabotropic glutamate 1 receptors attenuates behavioral effects of cocaine and methamphetamine in squirrel monkeys J. Pharmacol. Exp. Ther. 343 2012 214 224
4. J.B. Acri, S.R. Carter, K. Alling, B. Geter-Douglass, D. Dijkstra, and H. Wikström Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands Eur. J. Pharmacol. 281 1995 R7 R9
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders fifth ed. 2013 American Psychiatric Publishing Arlington, VA
6. J.B. Appel, R.T. Weathersby, K.A. Cunningham, P.M. Callahan, and R.L. Barrett Stimulus properties of dopaminergic drugs: comparisons involving selective agonists and antagonists Transduction Mechanisms of Drug Stimuli 1988 Springer Berlin Heidelberg 44 56
7. N.A. Ator, and R.R. Griffiths Principles of drug abuse liability assessment in laboratory animals Drug. Alcohol. Depend. 70 2003 S55 S72
8. L.E. Baker, E.E. Riddle, R.B. Saunders, and J.B. Appel The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds Behav. Pharmacol. 4 1993 69 79
9. L.E. Baker, K.A. Svensson, K.J. Garner, and A.K. Goodwin The dopamine D3 receptor antagonist PNU 99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine Eur. J. Pharmacol. 358 1998 101 109
10. M.G. Baladi, A.H. Newman, and C.P. France Feeding condition and the relative contribution of different dopamine receptor subtypes to the discriminative stimulus effects of cocaine in rats Psychopharmacol 2013 10.1007/s00213-013-3271-x
11. R.L. Balster, and G.E. Bigelow Guidelines and methodological reviews concerning drug abuse liability assessment Drug. Alcohol. Depend. 70 2003 S13 S40
12. R.L. Balster, and C.R. Schuster A comparison of d-amphetamine, l-amphetamine, and methamphetamine self-administration in rhesus monkeys Pharmacol. Biochem. Behav. 1 1973 67 71
13. M.L. Banks, and S.S. Negus Effects of extended cocaine access and cocaine withdrawal on choice between cocaine and food in rhesus monkeys Neuropsychopharmacol 35 2010 496 504
14. A.M. Barr, and A. Markou Psychostimulant withdrawal as an inducing condition in animal models of depression Neurosci. Biobehav. Rev. 29 2005 675 706
15. R.L. Barrett, and J.B. Appel Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine Psychopharmacol 99 1989 13 16
16. B.L. Baxter, M.I. Gluckman, L. Stein, and R.A. Scerni Self-injection of apomorphine in the rat: positive reinforcement by a dopamine receptor stimulant Pharmacol. Biochem. Behav. 2 1974 387 391
17. J. Bergman, B.K. Madras, S.E. Johnson, and R.D. Spealman Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys J. Pharmacol. Exp. Ther. 251 1989 150 155
18. W.K. Bickel, R.J. DeGrandpre, S.T. Higgins, and J.R. Hughes Behavioral economics of drug self-administration. I. Functional equivalence of response requirement and drug dose Life. Sci. 47 1990 1501 1510
19. R.D. Blitzer, and R.E. Becker Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism Psychopharmacol 85 1985 173 177
20. T.S. Bondareva, R. Young, and R.A. Glennon Central stimulants as discriminative stimuli: asymmetric generalization between (-)ephedrine and S(+)methamphetamine Pharmacol. Biochem. Behav. 74 2002 157 162
21. L.C.P. Botly, C.L. Burton, Z. Rizos, and P.J. Fletcher Characterization of methylphenidate self-administration and reinstatement in the rat Psychopharmacology 199 2008 55 66
22. S.B. Caine, and G.F. Koob Modulation of cocaine self-administration in the rat through D-3 dopamine receptors Science 260 1993 1814 1816
23. S.B. Caine, and G.F. Koob Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat Behav. Pharmacol. 6 1995 333 347
24. S.B. Caine, S.S. Negus, N.K. Mello, and J. Bergman Effects of dopamine D1-like and D2-like agonists in rats that self-administer cocaine J. Pharmacol. Exp. Ther. 291 1999 353 360
25. S.V. Calderon, and M. Klein A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States Neuropharmacol 87 2014 97 103
26. E.S. Calipari, T.J.R. Beveridge, S.R. Jones, and L.J. Porrino Withdrawal from extended-access cocaine self-administration results in dysregulated functional activity and altered locomotor activity in rats Eur. J. Neurosci. 2013 (epub ahead of print)
27. P.M. Callahan, J.B. Appel, and K.A. Cunningham Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine Psychopharmacol 103 1991 50 55
28. P.M. Callahan, and K.A. Cunningham Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in Rats J. Pharmacol. Exp. Ther. 266 1993 585 592
29. P.M. Callahan, R. de La Garza II, and K.A. Cunningham Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems Pharmacol. Biochem. Behav. 57 1997 601 607
30. R.W. Carlson, N.N. Kumar, E. Wong-Mckinstry, S. Ayyagari, N. Puri, F.K. Jackson, and S. Shashikumar Alcohol withdrawal syndrome Crit. Care. Clin. 28 2012 549 585
31. L.P. Carter, and R.R. Griffiths Principles of laboratory assessment of drug abuse liability and implications for clinical development Drug. Alcohol. Depend. 105S 2009 S14 S25
32. A.J. Christian, A.K. Goodwin, and L.E. Baker Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A Pharmacol. Biochem. Behav. 68 2001 371 377
33. F.C. Colpaert, C.J. Niemegeers, and P.A. Janssen Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments Pharmacol. Biochem. Behav. 4 1979 535 546
34. C.D. Cook, F.I. Carroll, and P.M. Beardsley RTI 113, a 3-phenyltropane analog, produces long-lasting cocaine-like discriminative stimulus effects in rats and squirrel monkeys Eur. J. Pharmacol. 442 2002 93 98
35. Z.D. Cooper, Y.G. Shi, and J.H. Woods Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats Psychopharmacol 212 2010 369 378
36. D.A. Cory-Slechta, C.L. Zuch, and R.A.V. Fox Comparison of the stimulus properties of a pre- vs. a putative postsynaptic dose of Quinpirole Pharmacol. Biochem. Behav. 55 1996 423 432
37. J.F. Cryan, D. Hoyer, and A. Markou Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents Biol. Psychiat 54 2003 49 58
38. K.A. Cunningham, and P.M. Callahan Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat Psychopharmacol 104 1991 177 180
39. P.W. Czoty, A. Makriyannis, and J. Bergman Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys Psychopharmacol 175 2004 170 178
40. P.W. Czoty, J.L. Martelle, and M.A. Nader Influence of abstinence and conditions of cocaine access on the reinforcing strength of cocaine in nonhuman primates Drug. Alcohol. Depend. 85 2006 213 220
41. P.W. Czoty, J.L. Martelle, F.I. Carroll, and M.A. Nader Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates Pharmacol. Biochem. Behav. 96 2010 274 278
42. G.D. D'Mello, and I.P. Stolerman Comparison of the discriminative stimulus properties of cocaine and amphetamine in rats Br. J. Pharmacol. 61 1977 415 422
43. R. de La Garza, and C.E. Johanson The discriminative stimulus properties of cocaine in the rhesus monkey Pharmacol. Biochem. Behav. 19 1983 145 148
44. V. Deroche-Gamonet, M. Darnaudery, L. Bruins-Slot, F. Piat, M. Le Moal, and P.V. Piazza Study of the addictive potential of modafinil in naïve and cocaine-experienced rats Psychopharmacol 161 2002 387 389
45. R.I. Desai, C.A. Paronis, J. Martin, R. Desai, and J. Bergman Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux J. Pharmacol. Exp. Ther. 333 2010 834 843
46. M.M. Dopheide, R.E. Morgan, K.R. Rodvelt, T.R. Schachtman, and D.K. Miller Modafinil evokes striatal [3H]dopamine release and alters the subjective properties of stimulants Eur. J. Pharmacol. 568 2007 112 123
47. L.A. Dykstra, P. Doty, A.R. Johnson, and M.J. Picker Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone Drug. Alcohol. Depend. 30 1992 227 234
48. N.B. Eddy, H. Halbach, H. Isbell, and M.H. Seevers Drug dependence: its significance and characteristics B. World. Health. Organ. 32 1965 721 733
49. M. Engeln, S.H. Ahmed, C. Vouillac, F. Tison, E. Bezard, and P.O. Fernagut Reinforcing properties of pramipexole in normal and parkinsonian rats Neurobiol. Dis. 49 2013 79 86
50. A. Ettenberg, M.A. Raven, D.A. Danluck, and B.D. Necessary Evidence for opponent-process actions of intravenous cocaine Pharmacol. Biochem. Behav. 64 1999 507 512
51. European Medicines Agency: Evaluation of Medicines for Human Use (EMEA) Guideline on the Non-Clinical Investigation of the Dependence Potential of Medicinal Products 2006
52. M. Filip, and E. Przegaliński The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats Pol. J. Pharmacol. 49 1997 21 30
53. R.D. Ford, and R.L. Balster Reinforcing properties of intravenous procaine in rhesus monkeys Pharmacol. Biochem. Behav. 6 1977 289 296
54. K.B. Freeman, D.J. Heal, A.C. McCreary, and W.L. Woolverton Assessment of ropinirole as a reinforcer in rhesus monkeys Drug. Alcohol. Depend. 125 2012 173 177
55. C. Frisch, R.J. Hasenohrl, C.M. Mattern, C.M. Hacker, and J.P. Huston Blockade of lithium chloride-induced conditioned place aversion as a test for antiemetic agents: comparison of metoclopramide with combined extracts of Zingiver officinale and Ginkgo biloga Pharmacol. Biochem. Behav. 52 1995 321 327
56. Food and Drug Administration (FDA)/Center for Drug Evaluation and Research (CDER) Draft Guidance for Industry: Assessment of Abuse Potential of Drugs 2010 Silver Spring, MD: US Department of Health and Human Service 2010 Retrieved from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM198650.pdf on August 29, 2013
57. K.J. Garner, and L.E. Baker Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline Pharmacol. Biochem. Behav. 64 1999 373 378
58. M. Gasior, J. Bergman, M.J. Kallman, and C.P. Paronis Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys Neuropsychopharmacol 30 2005 758 764
59. M.B. Gatch, C.M. Taylor, and M.J. Forster Locomotor and discriminative stimulus effects of 'bath salt' cathinones Behav. Pharmacol. 24 2013 437 447
60. R.A. Glennon, R. Young, B.R. Martin, and T.A. Dal Cason Methcathinone ("Cat"): an enantiomeric potency comparison Pharmacol. Biochem. Behav. 50 1995 601 606
61. L.H. Gold, and R.L. Balster Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil Psychopharmacol 126 1996 286 292
62. B.A. Gosnell, J.M. Yracheta, S.M. Bell, and K.E. Lane Intravenous self-administration of cathinone by rats Behav. Pharmacol. 7 1996 526 531
63. K.G. Götestam, and B.E. Andersson Self-administration of amphetamine analogues in rats Pharmacol. Biochem. Behav. 3 1975 229 233
64. J.H. Graham, and R.L. Balster Cocaine-like discriminative stimulus effects of procaine, dimethocaine and lidocaine in rats Psychopharmacol 110 1993 287 294
65. D.M. Grech, R.D. Spealman, and J. Bergman Self-administration of D1 receptor agonists by squirrel monkeys Psychopharmacol 125 1996 97 104
66. R.R. Griffiths, J.V. Brady, and J.D. Snell Progressive-ratio performance maintained by drug infusions: comparison of cocaine, diethylpropion, chlorphentermine, and fenfluramine Psychopharmacol 56 1978 5 13
67. R.R. Griffiths, G. Winger, J.V. Brady, and J.D. Snell Comparison of behavior maintained by infusions of eight phenylethylamines in baboons Psychopharmacol 50 1976 251 258
68. R.R. Griffiths, J.D. Findley, J.V. Brady, K. Dolan-Gutcher, and W.W. Robinson Comparison of progressive-ratio performance maintained by cocaine, methylphenidate and secobarbital Psychopharmacologia 43 1975 81 83
69. G.C. Hadlock, K.M. Webb, L.M. McFadden, P.W. Chu, J.D. Ellis, and S.C. Allen 4-methylmethacathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse J. Pharmacol. Exp. Ther. 339 2011 530 536
70. D.M. Hammerbeck, and C.L. Mitchell The reinforcing properties of procaine and d- amphetamine compared in rhesus monkeys J. Pharmacol. Exp. Ther. 204 1978 558 569
71. D.J. Heal, N.W. Buckley, J. Gosden, N. Slater, C.P. France, and D. Hackett A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to d-amfetamine, methylphenidate and modafinil Neuropharmacol 73 2013 348 358
72. S.G. Holtzman Differential interaction of GBR 12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocaine Psychopharmacol 155 2001 180 186
73. D.B. Horton, D.M. Potter, and A.N. Mead A translational pharmacology approach to understanding the predictive value of abuse potential assessments Behav. Pharmacol. 24 2013 410 436
74. L.L. Howell, and L.D. Byrd Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey J. Pharmacol. Exp. Ther. 258 1991 178 185
75. L.L. Howell, P.W. Czoty, M.J. Kuhar, and F.I. Carrol Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey J. Pharmacol. Exp. Ther. 292 2000 521 529
76. D. Huang, and M.C. Wilson Comparitive discriminative stimulus properties of dl-cathinone, d-amphetamine, and cocaine in rats Pharmacol. Biochem. Behav. 24 1986 205 210
77. S.R. Hursh Behavioral economics of drug self-administration and drug abuse policy J. Exp. Anal. Behav. 56 1991 377 393
78. S.R. Hursh, and A. Silberberg Economic demand and essential value Psychol. Rev. 115 2008 186 198
79. S.R. Hursh, and G. Winger Normalized demand for drugs and other reinforcers J. Exp. Anal. Behav. 64 1995 373 384
80. D.M. Hutcheson, B.J. Everitt, T.W. Robbins, and A. Dickinson The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat. Neurosci. 4 2001 943 947
81. C.E. Johanson The reinforcing properties of procaine, chloroprocaine and proparacaine in rhesus monkeys Psychopharmacol 67 1980 189 194
82. C.E. Johanson, and C.R. Schuster A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey J. Pharmacol. Exp. Ther. 193 1975 676 688
83. C.E. Johanson, and C.R. Schuster A comparison of the behavioral effects of l- and dl- cathinone and d-amphetamine J. Pharmacol. Exp. Ther. 219 1981 355 362
84. C.N. Jones, J.L. Howard, and S.T. McBennett Stimulus properties of antidepressants in the rat Pschopharmacol 67 1980 111 118
85. J.B. Kamien, and W.L. Woolverton A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys J. Pharmacol. Exp. Ther. 248 1989 938 946
86. J.B. Kamien, W.K. Bickel, J.R. Hughes, S.T. Higgins, and B.J. Smith Drug discrimination by humans compared to nonhumans: current status and future directions Psychopharmacol 111 1993 259 270
87. B.J. Kaminski, and R.R. Griffiths Intravenous self-injection of methcathinone in the baboon Pharmacol. Biochem. Behav. 47 1994 981 983
88. B.J. Kaminski, C.A. Sannerud, and R.R. Griffiths Intravenous self-injection of psychomotor stimulant-anorectics in the baboon Exp. Clin. Psychopharmacol. 4 1996 141 150
89. J.L. Katz, and K.L. Alling Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats Behav. Pharmacol. 11 2000 483 493
90. J.L. Katz, S. Izenwasser, and P. Terry Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects Psychopharmacol 148 2000 90 98
91. J. Kitanaka, N. Kitanaka, and M. Takemura Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review Neurochem. Res. 33 2008 204 219
92. M.S. Kleven, E.W. Anthony, and W.L. Woolverton Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys J. Pharmacol. Exp. Ther. 254 1990 312 317
93. L. Koetzner, A.L. Riley, and J.R. Glowa Discriminative stimulus effects of dopaminergic agents in rhesus monkeys Pharmacol. Biochem. Behav. 54 1996 517 523
94. M.N. Koffarnus, B. Greedy, S.M. Husbands, P. Grundt, A.H. Newman, and J.H. Woods The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats Psychopharmacol 203 2009 317 327
95. T.R. Kosten, and P.G. O'Connor Management of drug and alcohol withdrawal New. Engl. J. Med. 348 2003 1786 1795
96. J.A. Lago, and T.R. Kosten Stimulant withdrawal Addict 89 1994 1477 1481
97. X. Lamas, S.S. Negus, M.A. Nader, and N.K. Mello Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline Psychopharmacol 124 1996 306 314
98. R.J. Lamb, and R.R. Griffiths Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine Psychopharmacol 102 1990 183 190
99. E.B. Larson, F. Akkentli, S. Edwards, D.L. Graham, D.L. Simmons, I.N. Alibhai, E.J. Nestler, and D.W. Self Striatal regulation of ΔFosB, FosB, and sFos during cocaine self-administration and withdrawal J. Neurochem. 115 2010 112 122
100. G.A. Lemaire, and R.A. Meisch Oral drug self-administration in rhesus monkeys: interactions between drug amount and fixed-ratio size J. Exp. Anal. Behav. 44 1985 377 389
101. D.H. Li, R.Y. Depoortere, and M.W. Emmett-Oglesby Tolerance to the reinforcing effects of cocaine in a progressive ratio paradigm Psychopharmacol 116 1994 326 332
102. J.A. Lile, R.J. Charnigo, and M.A. Nader The relative reinforcing strength of methamphetamine and d-amphetamine in monkeys self-administering cocaine Behav. Pharmacol. 24 2013 482 485
103. J.A. Lile, Z. Wang, W.L. Woolverton, J.E. France, T.C. Gregg, H.M.L. Davies, and M.A. Nader The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamic J. Pharmacol. Exp. Ther. 307 2003 356 366
104. J.A. Lile, and M.A. Nader The abuse liability and therapeutic potential of drugs evaluated for cocaine addiction as predicted by animal models Curr. Neuropharmacol. 1 2003 21 46
105. W.J. Lynch, and M.E. Carroll Regulation of drug intake Exp. Clin. Psychopharmacol. 9 2001 131 143
106. J.A. Marusich, J.S. Beckmann, C.D. Gipson, and M.T. Bardo Methylphenidate as a reinforcer for rats: contingent delivery and intake escalation Exp. Clin. Psychopharmacol. 18 2010 257 266
107. M.L. McKenna, and B.T. Ho The role of dopamine in the discriminative stimulus properties of cocaine Neuropharmacol 19 1980 297 303
108. R.A. Meisch Oral drug self-administration: an overview of laboratory animal studies Alcohol 24 2001 117 128
109. K.F. Melia, and R.D. Spealman Pharmacological characterization of the discriminative- stimulus effects of GBR 12909 J. Pharmacol. Exp. Ther. 258 1991 626 632
110. L.D. Middaugh, K.K. McGroarty, C.H. Groseclose, and B. Adinoff Cocaine discrimination: relationship to local anesthetics and monoamine uptake inhibitors in C57BL/6 mice Psychopharmacol 136 1998 44 49
111. M. Minami Neuronal mechanisms for pain-induced aversion behavioral studies using a conditioned place aversion test Int. Rev. Neurobiol. 85 2009 135 144
112. C.P. Motbey, K.J. Clemens, N. Apetz, A.R. Winstock, J. Ramsey, and K.M. Li High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine J. Psychopharmacol. 27 2013 823 836
113. P. Munzar, Z. Justinova, S.W. Kutkat, and S.R. Goldberg Differential involvement of 5-HT2A receptors in the discriminative-stimulus effects of cocaine and methamphetamine Eur. J. Pharmacol. 436 2002 75 82
114. H. Myrick, R. Malcolm, B. Taylor, and S. LaRowe Modafinil: preclinical, clinical, and post-marketing surveillance - a review of abuse liability issues Ann. Clin. Psychiat 16 2004 101 109
115. National Institute on Drug Abuse (NIDA) Prescription drugs: abuse and addition Research Report Series 2001 Revised October 2011. Retrieved from http://www.drugabuse.gov/sites/default/files/rrprescription.pdf on September 3, 2013
116. S.S. Negus Choice between heroin and food in non-dependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine and methadone J. Pharmacol. Exp. Ther. 317 2006 711 723
117. S.S. Negus, and M.L. Banks Medications development for opioid abuse Cold. Spring. Harb. Perspect. Med. 1 2013 a012104
118. S.S. Negus, N.K. Mello, B.E. Blough, M.H. Baumann, and R.B. Rothman Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys J. Pharmacol. Exp. Ther. 320 2007 627 636
119. J.L. Newman, S.S. Negus, A. Lozama, T.E. Prisinzano, and N.K. Mello Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys Exp. Clin. Psychopharmacol. 18 2010 395 408
120. E.C. O'Connor, K. Chapman, P. Butler, and A.N. Mead The predictive validity of rat self- administration model for abuse liability Neurosci. Biobehav. Rev. 35 2011 912 938
121. M. Papasava, G. Singer, and C.L. Papasava Self-administration of phentermine by naïve rats: effects of body weight and a food delivery schedule Pharmacol. Biochem. Behav. 22 1985 1071 1073
122. N.E. Paterson, A. Fedolak, B. Olivier, T. Hanania, A. Ghavami, and B. Caldarone Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents Pharmacol. Biochem. Behav. 95 2010 449 456
123. R.L. Peltier, D.H. Li, D. Lytle, C.M. Taylor, and M.W. Emmett-Oglesby Chronic d- amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine J. Pharmacol. Exp. Ther. 277 1996 212 218
124. S.A. Perrine, I.S. Sheikh, C.A. Nwaneshiudu, J.A. Schroeder, and E.M. Unterwald Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat Neuropharmacol 54 2008 355 364
125. R. Pickens, and T. Thompson Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed ratio size J. Pharmacol. Exp. Ther. 161 1968 122 129
126. L. Pulvirenti, C. Balducci, M. Piercy, and G.F. Koob Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat J. Pharmacol. Exp. Ther. 286 1998 1231 1238
127. R. Ranaldi, Z. Wang, and W.L. Woolverton Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys Drug. Alcohol. Depend. 64 2001 209 217
128. A.K. Rehni, A.S. Jaggi, and N. Singh Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets CNS. Neurol. Disord-DR 12 2013 112 125
129. N.R. Richardson, and D.C.S. Roberts Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy J. Neurosci. Methods 66 1996 1 11
130. D.C.S. Roberts Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats Psychopharmacol 111 1993 202 206
131. D.C.S. Roberts, R. Phelan, L.M. Hodges, M.M. Hodges, B. Bennett, S. Childers, and H. Davies Self-administration of cocaine analogs by rats Psychopharmacol 144 1999 389 397
132. S. Rosenzweig-Lipson, and J. Bergman Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys J. Pharmacol. Exp. Ther. 267 1993 765 775
133. J.K. Rowlett A labor-supply analysis of cocaine self-administration under progressive- ratio schedules: antecedents, methodologies, and perspectives Psychopharmacol 153 2000 1 16
134. C.R. Rush, N.A. Ator, C.A. Simpson, and W.K. Bickel Behavioral pharmacology of commonly abused drugs: concordance between laboratory studies conducted with animals and humans M.E. Carroll, J.B. Overmier, Animal Research and Human Health: Advancing Human Welfare Through Behavioral Science 2001 American Psychological Association Washington, DC 101 114
135. C.R. Rush, T.H. Kelly, L.R. Hays, R.W. Baker, and A.F. Wooten Acute behavioral and physiological effects of modafinil in drug abusers Behav. Pharmacol. 13 2002 105 115
136. M.D. Schechter, and R.A. Glennon Cathinone, cocaine and methamphetamine: similarity of behavioral effects Pharmacol. Biochem. Behav. 22 1985 913 916
137. M.D. Schechter Discriminative characteristics of high and low cocaine administration: effect of other psychostimulants Pharmacol. Biochem. Behav. 56 1997 457 463
138. D.W. Self, and L. Stein The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats Brain. Res. 582 1992 349 352
139. P.B. Silverman, and K.A. Schultz Comparison of cocaine and procaine discriminative stimuli Drug. Dev. Res. 16 1989 427 433
140. R.S. Sinnott, R.H. Mach, and M.A. Nader Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys Drug. Alcohol. Depend. 54 1999 97 110
141. G. Sorensen, T.N. Sager, J.H. Petersen, L.T. Brennum, P. Thogersen, and C.H. Bengsten Aripiprazole blocks acute self-administration of cocaine and is not self- administered in mice Psychopharmacol 199 2008 37 46
142. R.D. Spealman, J. Bergman, B.K. Madras, and K.F. Melia Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes J. Pharmacol. Exp. Ther. 258 1991 945 953
143. R.D. Spealman Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys J. Pharmacol. Exp. Ther. 275 1995 53 62
144. R.D. Spealman Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys J. Pharmacol. Exp. Ther. 278 1996 1128 1137
145. C. Spyraki, and H.C. Fibiger Intravenous self-administration of nomifensine in rats: implications for abuse potential in humans Science 212 1981 1167 1168
146. D. Stafford, M.G. LeSage, and J.R. Glowa Progessive-ratio schedules of drug delivery in the analysis of drug self-administration: a review Psychopharmacol 139 1998 169 184
147. D. Stafford, M.G. LeSage, K.C. Rice, and J.R. Glowa A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule Drug. Alcohol. Depend. 62 2001 41 47
148. I.P. Stolerman, E. Childs, M.W. Ford, and K.A. Grant Role of training dose in drug discrimination: a review Behav. Pharmacol. 22 2011 415 429
149. I.P. Stolerman, and G.D. D'Mello Role of training conditions in discrimination of central nervous system stimulants by rats Psychopharmacol 73 1981 295 303
150. W.W. Stoops, J.A. Lile, M.T. Fillmore, P.E.A. Glaser, and C.R. Rush Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration Psychopharmacol 182 2005 186 193
151. K.J. Sufka Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain Pain 58 1994 355 366
152. T. Suzuki, Y. Fukuoka, T. Mori, M. Miyatake, and M. Narita Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats Eur. J. Pharmacol. 498 2004 157 161
153. A.H. Tang, and S.R. Franklin Discriminative stimulus effects of a low dose of apomorphine in the rat Psychopharmacol 91 1987 61 66
154. S.R. Tella, and S.R. Goldberg Subtle differences in the discriminative stimulus effects of cocaine and GBR-12909 Prog. Neuropsychopharmacol. Biol. Psychiat. 25 2001 639 656
155. S.R. Tella, B. Ladenheim, A.M. Andrews, S.R. Goldberg, and J.L. Cadet Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system J. Neurosci. 16 1996 7416 7427
156. S.R. Tella, B. Ladenheim, and J.L. Cadet Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine J. Pharmacol. Exp. Ther. 281 1997 508 513
157. P. Terry, J.M. Witkin, and J.L. Katz Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine J. Pharmacol. Exp. Ther. 270 1994 1041 1048
158. P. Terry, and J.L. Katz Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats Psychopharmacol 134 1997 201 212
159. J.W. Tidey, and J. Bergman Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs J. Pharmacol. Exp. Ther. 285 1998 1163 1174
160. Title 21 United States Code (USC) Controlled Substances Act, Section 801 (21USC801). Congressional findings and declarations: Controlled Substances. Retrieved from http://www.deadiversion.usdoj.gov/21cfr/21usc/801.htm on August 29, 2013.
161. Title 21 United States Code (USC) Controlled Substances Act, Section 812 (21USC812). Schedules of controlled substances. Retrieved from http://www.deadiversion.usdoj.gov/21cfr/21usc/812.htm on August 29, 2013.
162. M. Ukai, and H. Mitsunaga Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat Methods. Find. Exp. Clin. Pharmacol. 27 2005 645 649
163. K.J. Varner, K. Daigle, P.F. Weed, P.B. Lewis, S.E. Mahne, A. Sankaranarayanan, and P.J. Winsauer Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats Psychopharmacol 225 2013 675 685
164. G.B. Varty, and G.A. Higgins Investigations into the nature of a 7-OH-DPAT discriminative cue: comparison with d-amphetamine Eur. J. Pharmacol. 339 1997 101 107
165. N.D. Volkow, J.S. Fowler, J. Logan, D. Alesoff, W. Zhu, and F. Telang Effects of modafinil in dopamine transporters in the male human brain: clinical implications J. Am. Med. Assoc. 301 2009 1148 1154
166. S.K. Vosburg, C.L. Hart, M. Haney, E. Rubin, and R.W. Foltin Modafinil does not serve as a reinforcer in cocaine abusers Drug. Alcohol. Depend. 106 2010 233 236
167. L.R. Watterson, L. Hood, K. Sewalia, S.E. Tomek, S. Yahn, and C.R. Johnson The reinforcing and rewarding effects of methylone, a synthetic cathinone commonly found in "bath salts." Addict. Res. Ther. S9 2012 1 8
168. L.R. Watterson, P.R. Kufahl, N.E. Nemirovsky, K. Sewalia, M. Grabenauer, and B.F. Thomas Potent rewarding and reinforcing effects of the synthetic cathinone, 3,4- methylenedioxypyrovalerone (MDPV) Addict. Biol. 2013 10.1111/j.1369-1600.2012.00474.x
169. S. Wee, K.G. Anderson, M.H. Baumann, R.B. Rothman, B.E. Blough, and W.L. Woolverton Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs J. Pharmacol. Exp. Ther. 313 2005 848 854
170. S. Wee, and W.L. Woolverton Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine Drug. Alcohol. Depend. 75 2004 271 276
171. M.R. Weed, K.E. Vanover, and W.L. Woolverton Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys Psychopharmacol 113 1993 51 52
172. M.R. Weed, I.A. Paul, L.P. Dwoskin, S.E. Moore, and W.L. Woolverton The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys J. Pharmacol. Exp. Ther. 283 1997 29 38
173. M.R. Weed, and W.L. Woolverton The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys J. Pharmacol. Exp. Ther. 275 1995 1367 1374
174. R. West, and M. Gossop Overview: a comparison of withdrawal symptoms from different drug classes Addict 89 1994 1483 1489
175. K.M. Wilcox, I.A. Paul, G.A. Ordway, and W.L. Woolverton Role of the dopamine transporter and the sodium channel in the cocaine-like discriminative stimulus effects of local anesthetics in rats Psychopharmacol 157 2001 260 268
176. K.M. Wilcox, J.K. Rowlett, I.A. Paul, G.A. Ordway, and W.L. Woolverton On the relationship between the dopamine transporter and the reinforcing effects of local anesthetics in rhesus monkeys: practical and theoretical concerns Psychopharmacol 153 2000 139 147
177. M.C. Wilson, M. Hitomi, and C.R. Schuster Psychomotor stimulant self-administration as a function of dosage per injection in the rhesus monkey Psychopharmacologia 22 1971 271 281
178. M.C. Wilson, and C.R. Schuster Mazindol self-administration in the rhesus monkey Pharmacol. Biochem. Behav. 4 1976 207 210
179. G. Winger, and J.H. Woods Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding Drug. Alcohol Depend. 15 1985 123 130
180. R.A. Wise, A. Murray, and M.A. Bozarth Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing rats Psychopharmacol 100 1990 355 360
181. J.M. Witkin, D.E. Nichols, P. Terry, and J.L. Katz Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections J. Pharmacol. Exp. Ther. 257 1991 706 713
182. D.M. Wood, and M.W. Emmett-Oglesby Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine Psychopharmacol 95 1988 364 368
183. W.L. Woolverton Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys Pharmacol. Biochem. Behav. 26 1987 835 839
184. W.L. Woolverton Comparison of the reinforcing efficacy of cocaine and procaine in rhesus monkeys responding under a progressive-ratio schedule Psychopharmacol 120 1995 296 302
185. W.L. Woolverton, L.I. Goldberg, and J.Z. Ginos Intravenous self-administration of dopamine receptor agonists by rhesus monkeys J. Pharmacol. Exp. Ther. 230 1984 678 683
186. W.L. Woolverton, and C.E. Johanson Preference in rhesus monkeys given a choice between cocaine and d,l-cathinone J. Exp. Anal. Behav. 41 1984 35 43
187. W.L. Woolverton, J.B. Kamien, and L.I. Goldberg Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys J. Pharmacol. Exp. Ther. 241 1987 213 217
188. W.L. Woolverton, and R. Ranaldi Comparison of the reinforcing efficacy of two dopamine D2-like receptor agonists in rhesus monkeys using a progressive-ratio schedule of reinforcement Pharmacol. Biochem. Behav. 72 2002 803 809
189. R.A. Yokel, and R. Pickens Self-administration of optical isomers of amphetamine and methylamphetamine by rats J. Pharmacol. Exp. Ther. 187 1973 27 33
190. R.A. Yokel, and R.A. Wise Amphetamine-type reinforcement by dopaminergic agonists in the rat Psychopharmacol 58 1978 289 296
191. K. Yoshizawa, M. Narita, T. Mori, M. Miyatake, K. Isotani, and S. Tomiyasu Role of dopamine D2 and D3 receptors in mediating the U-50,488H discriminative cue: comparison with methamphetamine and cocaine Addict. Biol. 17 2012 949 955
192. R. Young, and R.A. Glennon Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex Pharmacol. Biochem. Behav. 45 1993 229 231
193. R. Young, and R.A. Glennon Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse Psychopharmacol 140 1998 250 256
194. T. Zorick, L. Nestor, K. Miotto, C. Sugar, G. Hellemann, G. Scanlon, R. Rawson, and E.D. London Withdrawal symptoms in abstinent methamphetamine-dependent subjects Addict 105 2010 1809 1818